Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00333125
NCT00333125
Completed
Phase 3

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Alcon Research0 sites319 target enrollmentApril 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGlaucomaOcular Hypertension
InterventionsTimolol VehicleTravoprost 40 mcg/ml + Timolol 5 mg/ml eye drops, solution (DuoTrav)Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (Cosopt)
DrugsTravoprost 40 mcg/ml + Timolol 5 mg/ml eye drops, solution (DuoTrav)Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (Cosopt)

Overview

Phase
Phase 3
Intervention
Timolol Vehicle
Conditions
Glaucoma
Sponsor
Alcon Research
Enrollment
319
Primary Endpoint
Mean Intra-Ocular Pressure (IOP)
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSimilar Trials

Overview

Brief Summary

The purpose of this study is to compare the intraocular pressure (IOP)-lowering efficacy and safety of two combination products in patients with open-angle glaucoma or ocular hypertension.

Registry
clinicaltrials.gov
Start Date
April 2006
End Date
February 2007
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •18 or older.
  • •Diagnosis of glaucoma or ocular hypertension.
  • •Other protocol-defined inclusion criteria may apply.

Exclusion Criteria

  • •Other protocol-defined exclusion criteria may apply.

Arms & Interventions

Travoprost/Timolol

Intervention: Timolol Vehicle

Travoprost/Timolol

Intervention: Travoprost 40 mcg/ml + Timolol 5 mg/ml eye drops, solution (DuoTrav)

Dorzolamide/Timolol

Intervention: Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (Cosopt)

Outcomes

Primary Outcomes

Mean Intra-Ocular Pressure (IOP)

Time Frame: 6 weeks

Similar Trials

Completed
Phase 4
Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStentsSubjects With Primary Open-angle Glaucoma (POAG)
NCT01252862Glaukos Corporation40
Completed
Phase 3
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular Hypertension
NCT00293787Alcon Research156
Completed
Phase 4
Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive AgentsOpen-angle Glaucoma
NCT02873806Glaukos Corporation53
Completed
Phase 3
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-Angle GlaucomaOcular Hypertension
NCT00293800Alcon Research173
Completed
Phase 4
Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive MedicationOpen Angle Glaucoma
NCT02868190Glaukos Corporation57